Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation.

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Abstract Text:

Mounira Habli,Richard J Levine,Cong Qian,Baha Sibai,

OBJECTIVE: The purpose of this study was to compare neonatal outcomes of pregnancies with preeclampsia or gestational hypertension with those of normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation separately. STUDY DESIGN: Secondary analysis of neonatal outcomes by week of delivery between 35 and 37 weeks 6 days of gestation to 4293 nulliparous women who were enrolled in a multicenter National Institute for Child Health and Human Development study. Outcomes included the percentage of neonatal intensive care unit admission, duration of neonatal hospitalization, and neonatal complications. RESULTS: As compared with normotensive pregnancies, hypertensive pregnancies that delivered at 35 and 36 weeks of gestation had higher rates of small for gestational age births (17.9% vs 1.7% [P < .05] and 33.3% vs 12.2% [P < .01], respectively) and neonatal intensive care unit admission (57.1% vs 34.5% [P < .05] and 33.3% vs 10.7% [P < .001]). The rate of neonatal intensive care unit admission (25.6% vs 8.7%; P < .001) and duration of neonatal stay (3.9 vs 2.0 days; P < .001) were greater in hypertensive pregnancies that delivered at 37 weeks of gestation.These differences were observed largely in women whose condition required labor induction, regardless of the severity of the hypertensive disease. CONCLUSION: Pregnancies with preeclampsia or gestational hypertension that delivered between 35 and 37 weeks of gestation had higher rates of neonatal intensive care unit admission, small for gestational age, and longer neonatal stay than normotensive pregnancies, regardless of the severity of the hypertensive disease.

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Publishing Authors By Initials

M Habli,RJ Levine,C Qian,B Sibai,

For similar diagnosis: prognosis: pregnancy outcome research abstracts see: diagnosis: prognosis: pregnancy outcome research

PUBMED ID PMID:

MEDLINE DATE:

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: American journal of obstetrics and gynecology

VOLUME: 197

Page Numbers: 406.e1-7

Journal Abbreviation: Am. J. Obstet. Gynecol.

ISSN: 1097-6868

DAY: 3

MONTH: Oct

YEAR: 2007

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370476

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Keywords Mesh Terms:

KEYWORDS: Pregnancy Outcome

MESH TERMS: prevention & control

Chemical & Substance for Abstract: Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Information

Substance Name: Calcium

Registry Number: 7440-70-2

Grant and Affiliation Information for Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation.

AFFILIATION: Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, OH, USA.

Country: United States

AGENCY: United States NICHD

GRANT: N01-HD-5-3246

ACRONYM: HD

MEDLINETA: Am J Obstet Gynecol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation Related Publications

• Acute fatty liver of pregnancy.
• Antioxidant therapy to prevent preeclampsia: a randomized controlled trial.
• Chronic hypertension in pregnancy.
• Duodeno-jejunal junction: a histoanatomical study with the concept of the existence of an "anatomical" sphincter.
• Electromyographic lag time and opening time: two novel noninvasive methods to investigate patients with anal outlet obstruction and their response to treatment.
• Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
• HELLP syndrome: an atypical presentation.
• Hypertensive disorders of pregnancy: the United States perspective.
• Immediate post-operative vocal changes in patients using laryngeal mask airway versus endotracheal tube.
• Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease?
• Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation.
• Prediction and prevention of recurrent preeclampsia.
• Pregnancy outcome in isolated single umbilical artery.
• The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome.
• The electromyographic activity of the external and internal urethral sphincters and urinary bladder on vaginal distension and its role in preventing vaginal soiling with urine during sexual intercourse.